United Therapeutics Corporation Form 144 Filed on May 7
Published on 5/7/2026

AI Summary
United Therapeutics Corporation (UTHR) has submitted Form 144 on May 7, indicating the intent to sell a specified amount of securities. Form 144 is typically filed by affiliates of a company prior to selling restricted or control securities. The filing details may influence market perception of UTHR, particularly among investors tracking insider sales or ownership changes. Specific quantities or transaction values were not disclosed in the filing.
Related News

Regulation
Abbott Laboratories (ABT) Faces Class-Action Lawsuit Over PediaSure
Jun 27

Regulation
UK Government Debates New ‘Golden Visa’ Scheme Amid Corruption Concerns
Jun 27

Regulation
US Court Rejects EPA Bid on Coal Regulations Impacting Markets
Jun 27

AI/Innovation
Anthropic (ANTH) Mythos 5 AI Model Approved for Limited Re-release
Jun 27